SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891618-02-002072
Filing Date
2002-04-30
Accepted
2002-04-30 17:14:36
Documents
5
Period of Report
2002-04-29
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K DATED APRIL 30, 2002 f81108e8-k.htm 8-K 10755
3 EXHIBIT 10.26 f81108ex10-26.txt EX-10.26 73382
4 EXHIBIT 10.27 f81108ex10-27.txt EX-10.27 34945
5 EXHIBIT 10.28 f81108ex10-28.txt EX-10.28 25790
6 EXHIBIT 99.1 f81108ex99-1.txt EX-99.1 3980
  Complete submission text file 0000891618-02-002072.txt   150867
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22570 | Film No.: 02628048
SIC: 2833 Medicinal Chemicals & Botanical Products